Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Timolol in operated closed-angle glaucoma

C I Phillips

    The British Journal of Ophthalmology
    |April 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Timolol eye drops show promise in controlling intraocular pressure for patients with closed-angle glaucoma, especially after surgery. This beta-blocker offers an effective alternative to miotics, without causing pupil constriction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Systematic risks from chloramphenicol eye drops.

    The British journal of general practice : the journal of the Royal College of General Practitioners·2010
    Same author

    Altered photic and non-photic phase shifts in 5-HT(1A) receptor knockout mice.

    Neuroscience·2008
    Same author

    Risk of systemic toxicity from topical ophthalmic chloramphenicol.

    Scottish medical journal·2008
    Same author

    Influence of dehydroepiandrosterone on rabbit intraocular pressure.

    Ophthalmic research·2000
    Same author

    Some plasma constituents correlate with human cataract location and nuclear colour.

    Ophthalmic research·1997
    Same author

    Pathological cupping in normal pressure glaucoma is probably not due to low CSF pressure.

    Acta ophthalmologica Scandinavica·1996
    Same journal

    Novel technique for treating extraocular muscle adherence after fracture repair.

    The British journal of ophthalmology·2026
    Same journal

    Safe use of fluorinated gases in vitreoretinal surgery: learning from patient safety incidents with expert panel recommendations from the British and Eire Association of Vitreoretinal Surgeons (BEAVRS).

    The British journal of ophthalmology·2026
    Same journal

    Fast progressors in Asian normal-tension glaucoma: 10 years and beyond in a longitudinal cohort.

    The British journal of ophthalmology·2026
    Same journal

    Identifying patients with poor visual outcomes after primary rhegmatogenous retinal detachment surgery using machine learning.

    The British journal of ophthalmology·2026
    Same journal

    Incidence of bilateral disease and choroidal neovascularisation in punctate inner choroiditis.

    The British journal of ophthalmology·2026
    Same journal

    Reference map of multimodal vision deficits in intermediate age-related macular degeneration: contrast sensitivity and low-contrast visual acuity.

    The British journal of ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Glaucoma management often involves medications to control intraocular pressure (IOP).
    • Closed-angle glaucoma presents unique challenges due to pupillary dynamics.
    • Timolol, a non-selective beta-adrenergic receptor antagonist, is evaluated for its IOP-lowering effects.

    Purpose of the Study:

    • To assess the efficacy of timolol eye drops in managing intraocular pressure in eyes operated for closed-angle glaucoma.
    • To compare the effects of timolol with other glaucoma medications like pilocarpine and adrenaline.

    Main Methods:

    • Tonometry was performed on 9 eyes across 7 patients.
    • Timolol eye drops were administered, and their effects on IOP were monitored.
    • Case studies documented the response to timolol, alone or in combination with other agents.

    Related Experiment Videos

    Main Results:

    • Timolol consistently reduced intraocular pressure in operated eyes.
    • In one case, timolol 0.5% was as effective as pilocarpine and adrenaline.
    • Timolol's effect was additive to pilocarpine and adrenaline in other cases, with potential long-term efficacy variations.
    • Timolol demonstrated a beneficial effect that could be reversed upon withdrawal, though pressure sometimes increased despite discontinuation.

    Conclusions:

    • Timolol eye drops are valuable for controlling intraocular pressure in post-operative glaucoma, particularly closed-angle glaucoma.
    • Its lack of effect on pupil size is advantageous over miotics, reducing risks like posterior synechiae and iridocyclitis.
    • Timolol offers a potentially safer and effective option for managing complex glaucoma cases.